QIAGEN Gets FDA Approval for Ayvakit Companion Diagnostic
The U.S. FDA has approved QIAGEN’s therascreen PDGFRA kit, which is a companion diagnostic for the gastrointestinal cancer drug Ayvakit.
Read MorePosted by Andy Lundin | Aug 10, 2023 | Gastrointestinal Infections |
The U.S. FDA has approved QIAGEN’s therascreen PDGFRA kit, which is a companion diagnostic for the gastrointestinal cancer drug Ayvakit.
Read MorePosted by Andy Lundin | Aug 9, 2023 | Lab Equipment |
Lonza launched an absorbance microplate reader that joins a portfolio of optimized instruments for streamlined endotoxin and pyrogen testing.
Read MorePosted by Andy Lundin | Aug 7, 2023 | Cardiovascular |
The FDA cleared the AXINON LDL-p Test System as a tool physicians can use to measure lipoproteins for those at risk of cardiovascular disease.
Read MorePosted by Chris Wolski | Aug 7, 2023 | Diabetes & Metabolic Diseases |
While A1c is the diagnostic gold standard for determining if a patient has diabetes, there are a variety of tests that provide flexibility.
Read MorePosted by Andy Lundin | Aug 3, 2023 | Respiratory Disease |
Cue’s new test would differentiate between influenza A/B, RSV, and COVID simultaneously, with results delivered in approximately 25 minutes.
Read More